Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)
- Citation:
- J Thorac Oncol vol 12 (5) 843-849
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- CA31946, CA33601, U10CA180821, U10CA180882, U10CA180790, U10CA180838, U10CA180833, U10CA180836, U10CA180857, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180836, U10 CA180857, U10 CA180790, U10 CA180882, U10 CA180833, U10 CA180838, U10 CA180844
- Corr. Author:
- Authors:
- Maria Q. Baggstrom Mark A. Socinski Xiaofei F. Wang Lin Gu Thomas E. Stinchcombe Martin J. Edelman Sherman Baker JR Josephine Feliciano Paul Novotny Olwen Hahn Jeffrey A. Crawford Everett E. Vokes
- Networks:
- FL086, LAPS-IL057, LAPS-MD017, LAPS-MO011, LAPS-NC010, MD015, VCU
- Study
- CALGB-30607
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-70701
- Phases:
- 3, N/A
- Keywords:
- Sunitinib, Maintenance, NSCLC, Tyrosine kinase inhibitor